$VXRT Question is, will Janssen (of $JNJ) be licensing Vaxart's oral vaccine platform for Influenza soon? If so, are they trying to negotiate rights for COVID19 application too? Vaxart 8-K last night included some links to seemingly unrelated PRs: https://t.co/UWLn2pUQvI https://t.co/LNMIecPgEw